Evidence map›Paper›PMID 31373864›Full record

SynthesisHuman vaccines & immunotherapeutics2020

The clinical and economic burden of varicella in the Middle East: a systematic literature review.

Nawal Al Kaabi, Fatma Mohd Ali Sultan Al Olama, Mamoun Al Qaseer, Idris Al Ubaidani, Ener Cagri Dinleyici, Wail Ahmad Hayajneh, Abdul Rahman Bizri, Maysoon Loulou, Tidiane Ndao, Lara J Wolfson

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Global varicella vaccination programs.Clinical and experimental pediatrics · 2022
    Article
  14. Acceptance of varicella vaccination.Human vaccines & immunotherapeutics · 2021
    Article
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 7 countries.

Nawal Al KaabiDepartment of Pediatrics, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Fatma Mohd Ali Sultan Al OlamaChild Healthcare Unit, Dubai Health Authority, Dubai, UAE.
Mamoun Al QaseerVirology Unit, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait.
Idris Al UbaidaniDepartment of Communicable Disease Surveillance & Control, Directorate General of Health Affairs, Ministry of Health HQ, Muscat, Sultanate of Oman.
Ener Cagri DinleyiciDepartment of Pediatrics, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Wail Ahmad HayajnehFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Abdul Rahman BizriDepartment of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Maysoon LoulouMSD Idea Middle East, Dubai, UAE.
Tidiane NdaoMSD Morocco S.A.R.L., Casablanca, Morocco.
Lara J WolfsonMerck & Co., Inc. Center for Observational and Real-World Evidence (CORE), Kenilworth, NJ, USA.ORCID 0000-0002-6454-3368
American University of Beirut Medical Center · LBDubai Health Authority · AEEskişehir Osmangazi University · TRJordan University of Science and Technology · JOMerck & Co., Inc., Rahway, NJ, USA (United States) · USMinistry of Health · OMMubarak Al Kabeer Hospital · KWShaikh Khalifa Medical City · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This systematic literature review was conducted to better understand the epidemiology and burden of varicella across the Middle East, gain insight into the evidence to support using universal varicella vaccination (UVV), and identify potential data gaps. Both epidemiology and economic data on the burden of varicella were limited and varied significantly. Most of the data focussed on varicella burden in the absence of a UVV program. In the absence of UVV, varicella incidence is increasing across this region with varicella infection associated with substantial morbidity. Although limited, data on the impact of vaccination at a population level indicated UVV programs reduce varicella incidence and hospitalizations, in line with global experience. Further research and action are needed to better understand varicella epidemiology in the Middle East, increase awareness and understanding in the region, and provide local data to support national public-health decisions regarding the implementation of UVV programs.

Indexed as

Cost of IllnessChickenpoxHospitalizationHumansImmunization ProgramsIncidenceMiddle EastSeroepidemiologic StudiesVaccination CoverageMiddle Eastseroprevalencesystematic literature reviewvaccinationvaricella

Identifiers

PMID31373864
PMCPMC7012098
OpenAlexW2965538301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.